NeurAxis, Inc. (NRXS)
NYSEAMERICAN: NRXS · Real-Time Price · USD
2.900
+0.140 (5.07%)
Oct 22, 2024, 4:00 PM EDT - Market closed
NeurAxis Revenue
NeurAxis had revenue of $611.50K in the quarter ending June 30, 2024, a decrease of -5.34%. This brings the company's revenue in the last twelve months to $2.27M, down -15.50% year-over-year. In the year 2023, NeurAxis had annual revenue of $2.46M, down -8.37%.
Revenue (ttm)
$2.27M
Revenue Growth
-15.50%
P/S Ratio
7.29
Revenue / Employee
$119,319
Employees
19
Market Cap
20.24M
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 2.46M | -224.69K | -8.37% |
Dec 31, 2022 | 2.68M | -36.55K | -1.34% |
Dec 31, 2021 | 2.72M | 791.06K | 40.98% |
Dec 31, 2020 | 1.93M | - | - |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionNRXS News
- 22 hours ago - NeurAxis Announces New CPT® Category I Code for Percutaneous Electrical Nerve Field Stimulation - GlobeNewsWire
- 4 weeks ago - NeurAxis to Participate in the Lytham Partners Fall 2024 Investor Conference on October 1, 2024 - GlobeNewsWire
- 2 months ago - NeurAxis Announces Geisinger Health Plan Medical Policy Coverage for PENFS, Effective September 15 2024 - GlobeNewsWire
- 2 months ago - NeurAxis Announces BCBS of Vermont Medical Policy Coverage for PENFS, effective October 1st 2024 - GlobeNewsWire
- 2 months ago - NeurAxis, Inc. (NRXS) Q2 2024 Earnings Call Transcript - Seeking Alpha
- 2 months ago - NeurAxis Reports Second Quarter 2024 Financial Results - GlobeNewsWire
- 4 months ago - NeurAxis Announces New Submission to the FDA for the Expansion of its IB-Stim Label; Provides Compliance with NYSE Guidelines on Audit Disclosure - GlobeNewsWire
- 5 months ago - NeurAxis, Inc. (NRXS) Q1 2024 Earnings Call Transcript - Seeking Alpha